Taking place today: SelectScience Biopharma Summit 2023

Explore the latest developments in biopharma with fellow scientists, manufacturers, and regulatory experts

4 Sept 2023
Jemima Arnold
Editorial Assistant

Editorial article

Join us for the SelectScience® Virtual Biopharma Summit 2023, taking place today – September 5.

Covering hot topics spanning cell and gene therapy, drug delivery, nanomaterials, artificial intelligence, machine learning, vaccine discovery and development, and much more, this free-to-attend online event offers an interactive forum for scientists and manufacturers to connect, showcase research, and share technology solutions.

Now in its third year, the Summit offers a crucial platform for scientists, manufacturers, and regulatory experts to connect and share critical updates in the field, featuring eminent speakers, technology workshops, interactive resource hubs from leading manufacturers, and dedicated networking sessions. Attendees will also be able to view academic posters submitted by our global scientific community, leave comments, ask questions, and prompt collaboration through 1-on-1 chat facilities.


Reserve your free place today

Register now and read on to view the full agenda:

Keynote Speaker

Dr. Jared R. Auclair
Vice Provost Research Economic Development and Director of Bioinnovation, Northeastern University

Analytical technology solutions for biopharmaceuticals from research through commercialization

Agenda

Tuesday, September 5

The Summit sessions take place in two concurrent tracks. Track 1 talks cover a range of topics in Bioanalysis, while Track 2 is focused on Digital transformation. Times in bold are shown as British Summer Time (BST).

11:00
 12:00 (CEST) 
06:00 (EDT)
03:00 (PDT)

Opening address & Poster session

 11:15
 12:15 (CEST) 
06:15 (EDT)
03:15 (PDT)

Keynote: Analytical technology solutions for biopharmaceuticals from research through commercialization

Dr. Jared R. Auclair, Vice Provost Research Economic Development and Director of Bioinnovation, Northeastern University

Best Practices in Biobanking for Biopharmaceutical Research

Amy Armstrong, Senior Product Manager for Thermo Fisher Scientific Laboratory Plastics Essentials, and Wilfredo Marin, Senior Product Application Scientists for Thermo Fisher Scientific Biobanking and Cryopreservation 12:00
 13:00 (CEST) 
07:00 (EDT)
04:00 (PDT)

Pharma compliance

David Grant, Global Product Manager, ELGA Labwater

How to make your maintenance smarter

Tim Horton, Senior Global Change Facilitator in Client Delivery, BioPhorum / Celine Anoufa, Overall Equipment Effectiveness Leader, Cytiva / Burkhard Wandelt, Head of Global Maintenance Management, Merck / Jonas Berge, Senior Director, Applied Technology, Emerson / Niall Foy, MAM CoE Asset Management Systems Business Process Owner, Janssen 12:45
 13:45 (CEST) 
07:45 (EDT)
04:45 (PDT)

Standardizing traceability of personalized cell and gene therapies

Rebecca Street-Howard, Cell and Gene Therapy Systems Director, GSK / Juan Jaime, Supply Chain Business Technology Leader, Janssen / Elena Rivkin , Section Lead, Business Analysis and User Experience, Roche / Kim Wilson, Life Sciences Industry Business Consultant, Dassault Systèmes / Fred Dardy, CGT Enterprise Architect, Roche / Judith Koliwer, Principal Consultant, Cell and Gene Therapy, Körber / David Gray, Manager, Global Solution Architects, Emerson / Jon Butterfield, Senior MES Analyst, Lonza

Vision for digital integration of sponsor and contract organizations

Roman Havriliak, Senior Director, Global Supply Chain Solutions Deploy, Embed & Optimize, Pfizer / Alexander Ulbrich, Vetter / Marcos García López, Associate Manager of Analytics and Digitalization at Global Contract Manufacturing, Novo Nordisk / Michalle Adkins, Director, Life Sciences Strategy and Direction, Emerson / David Brick, Sr. Director, Data Sciences, IDBS / Chris Demers, Global Lead - Plant Data and Analytics, Catalent 14:15
 15:15 (CEST) 
09:15 (EDT)
06:15 (PDT)

Customizing biosafety cabinets: A holistic approach

Dr. Julianne Baron, President, Science and Safety Consulting, LLC / Jim Wagner, President, Controlled Environment Consulting, LLC / Bill Peters, President, NuAire, Inc / Seth De Penning, Product Marketing Manager, NuAire, Inc 15:00
 16:00 (CEST) 
10:00 (EDT)
07:00 (PDT)

Insight Biologics - an advanced platform solution for characterizing oligonucleotide products and impurities

Dr. Atsuhiko (Ash) Toyama, Global Product Manager (LCMS), Shimadzu Corporation

Revolutionizing live-cell imaging with AI: A label-free approach to assess viability

Jasmine Trigg, Scientist, Sartorius 15:45
 16:45 (CEST) 
10:45 (EDT)
07:45 (PDT)

Proteomic investigation of ER stress mechanisms in recombinant Chinese hamster ovary cells to improve bioproductivity

Dr. Paula Meleady, Principal Investigator, Dublin City University 16:30
 17:30 (CEST) 
11:30 (EDT)
08:30 (PDT)

Bispecific antibodies in oncology: Bridging targets for precision cancer therapy

Dr. Peter Betz Wolff, Scientist, AD Bioassay

Mycoplasma Avoid Contamination and Detection

Sartorius 17:15
 18:15 (CEST) 
12:15 (EDT)
09:15 (PDT)

SIFT-MS: Revolutionizing workflows for residual solvents and volatile impurities analyses

Dr. Mark Perkins, Element Materials Technology / Dr. Leslie Silva, Syft Technologies / Dr. Vaughan Langford, Syft Technologies

Rapid sterility test systems in the pharmaceutical industry

Sven Deutschmann, Head of Global ASAT, Roche Diagnostics GmbH / Jonas van den Berg, Global Quality Manager, Roche / Marja Claassen, Program Director, Biotech Development Center, Merck 18:00
 19:00 (CEST) 
13:00 (EDT)
10:00 (PDT)

Current status of transporter-mediated drug delivery

Dr. Elena Puris, Postdoctoral Researcher, Heidelberg University

Innovation and collaboration in regulatory science

Isabelle Lequeux, BioPhorum Regulatory Lead / Sue Plant, BioPhorum Director Regulatory CMC 18:45
 19:45 (CEST) 
13:45 (EDT)
10:45 (PDT)

Translational models for drug discovery in neuroinflammation

Elise Malavasi, Concept Life Sciences

Engineering synthetic nanocarriers for cell-selective therapy

Prof. Evan Scott, Kay Davis Professor, Associate Professor of Biomedical Engineering, Northwestern University

Sponsors

Register for free to reserve a place today — you’ll be able to drop in and out as you wish during the Summit.

Watch this space for further updates and follow our social media channels:

Spread the word using #BiopharmaSummit2023

    


    

Links

Tags

Sample ManagementSample management systems include sample storage devices such as freezers and plate storers, sample environment enclosures and sample organization, retrieval and sorter systems. Useful system features include high-throughput, automation, robotic arms, automated liquid handling and associated database systems. Accessories in sample management include barcode scanners, heat sealers and tubes.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Robotic WorkstationsRobotic workstations are automated platforms enabling the user to perform high-throughput, multi-application processes, from sample preparation tasks such as PCR set-up, DNA purification and NGS library preparation, to integrated sample prep and analysis workstations. Automation makes processes consistent, fast, precise and fully walk-away. Find the best robotic workstations in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Discovery SoftwareComputational techniques used in both the chemistry and biology aspects of drug discovery, for data acquisition, processing and storage. Software is used for analysis of pathways, target identification, genomics, proteomics, modelling, lead identification, compound analysis and drug modelling among many others. Drug DeliveryDrug Delivery refers to dosage form, route of administration, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via the biopharmaceutical or small molecule drug's formulation, but it may also involve medical devices or drug-device combination products. Considerations include instrumentation, software and services. RegulatoryPharmaceutical regulations impact on all areas of drug development, manufacture and control and supply. Services are provided from the early stages of drug development and clinical trials through to dossier submission, approval and marketing. Regulatory also includes submission of analytical studies from the pharmaceutical product and safety. BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.